The second category is ‘other demyelinating diseases of the CNS’, which includes diagnoses such as myelin oligodendrocyte glycoprotein antibody–associated disease where the host immune system attacks myelin in the brain, optic nerve and spinal cord. This evidence concerns the gene MOG and demyelinating disease of central nervous system.